Neural cell adhesion molecule

Ncam Launches Mk2 Connection Box for Real-Time Camera Tracking

Retrieved on: 
Tuesday, June 15, 2021

By eliminating the need to attach a server directly to the camera, the Mk2 Connection Box makes the Ncam setup significantly lighter lowering the physical barriers to help teams utilize the same cutting-edge camera tracking technology used on The Witches , the Fortnite World Cup and viral graphics for The Weather Channel.

Key Points: 
  • By eliminating the need to attach a server directly to the camera, the Mk2 Connection Box makes the Ncam setup significantly lighter lowering the physical barriers to help teams utilize the same cutting-edge camera tracking technology used on The Witches , the Fortnite World Cup and viral graphics for The Weather Channel.
  • No one wants to be tied down when they are getting their shot; with the Mk2 Connection Box, you dont have to be, said Nic Hatch, CEO of Ncam.
  • Seamlessly integrated with Unreal Engine, the Ncam Reality system includes the Mk2 Camera Bar, Mk2 Server and Ncam Reality software , which work together to blend live action and CG content in any indoor or outdoor environment, regardless of camera, lens or rig.
  • Since the Mk2 Connection Box works with any Ncam-compatible server, users no longer have to buy the Mk2 Server option, unlocking a more accessible way to take advantage of Ncams advanced camera tracking technology.

Menarini Receives European Commission Approval of ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Retrieved on: 
Thursday, January 21, 2021

ELZONRIS(tagraxofusp) is indicated as monotherapy for the first-line treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN).

Key Points: 
  • ELZONRIS(tagraxofusp) is indicated as monotherapy for the first-line treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN).
  • ELZONRIS should be administered under the supervision of a physician experienced in the use of anti-cancer agents.
  • The BPDCN cell of origin is the plasmacytoid dendritic cell (pDC) precursor.
  • The World Health Organization (WHO) termed this disease "BPDCN" in 2008; previous names included blastic NK cell lymphoma and agranular CD4+/CD56+ hematodermic neoplasm.

CHMP Adopted Positive Opinion for ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Retrieved on: 
Friday, November 13, 2020

The CHMP opinion will now be reviewed by the European Commission, which has the authority to grant marketing authorization for human medicines throughout the European Union (EU).

Key Points: 
  • The CHMP opinion will now be reviewed by the European Commission, which has the authority to grant marketing authorization for human medicines throughout the European Union (EU).
  • For this reason, we are particularly thrilled to be one step closer to making ELZONRIS available for BPDCN patients".
  • The BPDCN cell of origin is the plasmacytoid dendritic cell (pDC) precursor.
  • The World Health Organization (WHO) termed this disease "BPDCN" in 2008; previous names included blastic NK cell lymphoma and agranular CD4+/CD56+ hematodermic neoplasm.

CHMP Adopted Positive Opinion for ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Retrieved on: 
Friday, November 13, 2020

The CHMP opinion will now be reviewed by the European Commission, which has the authority to grant marketing authorization for human medicines throughout the European Union (EU).

Key Points: 
  • The CHMP opinion will now be reviewed by the European Commission, which has the authority to grant marketing authorization for human medicines throughout the European Union (EU).
  • For this reason, we are particularly thrilled to be one step closer to making ELZONRIS available for BPDCN patients".
  • The BPDCN cell of origin is the plasmacytoid dendritic cell (pDC) precursor.
  • The World Health Organization (WHO) termed this disease "BPDCN" in 2008; previous names included blastic NK cell lymphoma and agranular CD4+/CD56+ hematodermic neoplasm.

Virtual Production Pioneer Ncam Selects Liaison to Lead Public Relations and Social Media Strategy

Retrieved on: 
Wednesday, October 28, 2020

PORTLAND, Ore., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Liaison , an award-winning public relations firm specializing in 3D technology, today announces the addition of virtual production technologies creator, Ncam , to its agency roster.

Key Points: 
  • PORTLAND, Ore., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Liaison , an award-winning public relations firm specializing in 3D technology, today announces the addition of virtual production technologies creator, Ncam , to its agency roster.
  • Drawing on 20+ years of experience in emerging tech, Liaison will design strategic marketing, public relations and social media campaigns aimed at positioning Ncam as the industry-leading real-time camera tracking solution for film, broadcast and live events.
  • We are at a pivotal moment in the mainstreaming of virtual production technologies, said Ncam CEO Nic Hatch.
  • As industries increasingly embrace real-time workflows, Ncam has continued to innovate, most recently with the release of its Ncam Reality suite .